Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 2/20 | 0.78 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25046238 | 1.00 | KEAP1 (0.78) | KEAP1NFE2L2 | |
| SCHEMBL29699866 | 0.89 | KEAP1 (0.86) | KEAP1NFE2L2 | |
| SCHEMBL29698477 | 0.89 | KEAP1 (0.78) | KEAP1NFE2L2 | |
| SCHEMBL29378881 | 0.88 | KEAP1 (1.00) | KEAP1NFE2L2 | |
| SCHEMBL29358083 | 0.88 | KEAP1 (1.00) | KEAP1NFE2L2 | |
| SCHEMBL29698482 | 0.85 | KEAP1 (0.82) | KEAP1NFE2L2 | |
| SCHEMBL24473700 | 0.82 | KEAP1 (0.69) | KEAP1NFE2L2 | |
| SCHEMBL31735947 | 0.82 | KEAP1 (0.69) | KEAP1NFE2L2 | |
| SCHEMBL29698419 | 0.81 | KEAP1 (0.67) | KEAP1NFE2L2 | |
| SCHEMBL29698498 | 0.81 | KEAP1 (0.66) | KEAP1NFE2L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240358625-A1 | STABILIZATION OF MYCOSPORINE-LIKE AMINO ACIDS | NAGASE & CO., LTD. (JP) | 2024-10-31 | — | — | US | disclosed |
| CN-113980918-B | Antarctic ice algae MAAs synthetase, and coding gene and application thereof | 自然资源部第一海洋研究所 | 2023-11-24 | — | — | CN | disclosed |
| WO-2022187271-A1 | GADUSOL AND GADUSPORINE COMPOUND FORMULATIONS FOR TOPICALS | GADUSOL LABORATORIES, INC. (US) | 2022-09-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240358625-A1 | STABILIZATION OF MYCOSPORINE-LIKE AMINO ACIDS | GDA, MYCBP, MYC | KEAP1 3604/4885NFE2L2 3032/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.